Abstract 1658: M3814, a novel investigational DNA-PK inhibitor: enhancing the effect of fractionated radiotherapy leading to complete regression of tumors in mice
Zenke, Frank T., Zimmermann, Astrid, Sirrenberg, Christian, Dahmen, Heike, Vassilev, Lubo, Pehl, Ulrich, Fuchss, Thomas, Blaukat, Andree
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
Abstract 4198: Highly potent and selective DNA-PK inhibitor M3814 with sustainable anti-tumor activity in combination with radiotherapy
Fuchss, Thomas, Mederski, Werner W., Emde, Ulrich, Buchstallter, Hans-Peter, Zenke, Frank, Zimmermann, Astrid, Sirrenberg, Christian, Vassilev, Lubo, Damstrup, Lars, Urbahns, Klaus, Blaukat, Andree
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Published in Cancer research (Chicago, Ill.) (01.07.2017)
Get full text
Journal Article
Inhibition of p53-MDM2 Interaction by Small-Molecule Antagonist of MDM2 Effectively Induces Apoptosis in Leukemias
Kojima, Kensuke, Konopleva, Marina, Shikami, Masato, Cabreira-Hansen, Maria, Jackson, C. Ellen, Shpall, Elizabeth J., Kornblau, Steven M., Vassilev, Lubo T., Andreeff, Michael
Published in Blood (16.11.2004)
Published in Blood (16.11.2004)
Get full text
Journal Article